This program will include a discussion of offlabel treatments not approved by the FDA for use in the US Tardive Dyskinesia Clinical Presentation of Tardive Dyskinesia Videos of Patients With Tardive Dyskinesia ID: 779056
Download The PPT/PDF document "5 Things NPs and PAs Need to Know About ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
5 Things NPs and PAs Need to Know About Tardive Dyskinesia
Slide2Slide3This program will include a discussion of off-label treatments not approved by the FDA for use in the US.
Slide4Tardive Dyskinesia
Slide5Clinical Presentation of Tardive Dyskinesia
Slide6Videos of Patients With Tardive Dyskinesia
Slide7Subtypes of TD
Slide8Diagnosis: Clinical Signs and Symptoms
Slide9Diagnosis: AIMS
Slide10Scoring the AIMS
Procedure and Examples of Movements
Slide11Scoring the AIMS
Global Judgments and Dental Status
Slide12Pathophysiology of TD
Slide13Prevalence of TD
Slide14Risk Factors
Slide15Prevent Onset and Minimize Risk
Slide16Treatment of TDAgents Used Prior to 2017
Slide17Vesicular Monoamine Transporter 2 Inhibitors
Slide18Tetrabenazine
Slide19Deutetrabenazine
Slide20AIM-TD: Deutetrabenazine
Slide21Valbenazine
Slide22KINECT 3: Valbenazine
Slide23Updated AAN Treatment Algorithm
Slide24Monitoring Patients on VMAT Inhibitors
Slide25Role of Physician Assistants and Nurse Practitioners in TD Management
Slide26Practice Pearls for Managing TD
Slide27Concluding Remarks
Slide28Abbreviations
Slide29Abbreviations (cont)